» Authors » Andrew Ippoliti

Andrew Ippoliti

Explore the profile of Andrew Ippoliti including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 43
Citations 1031
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Jacobs J, Goudarzi M, Lagishetty V, Li D, Mak T, Tong M, et al.
Genome Med . 2022 Aug; 14(1):91. PMID: 35971134
Background: Crohn's disease (CD) patients demonstrate distinct intestinal microbial compositions and metabolic characteristics compared to unaffected controls. However, the impact of inflammation and underlying genetic risk on these microbial profiles...
2.
Halloran B, Jamil L, Lo S, Reeson M, Vasiliauskas E, Targan S, et al.
Inflamm Bowel Dis . 2020 Nov; 27(8):1248-1255. PMID: 33155643
Background: Crohn disease (CD) affects the small bowel in 80% of patients. Double balloon endoscopy (DBE) provides the potential for direct and extensive mucosal visualization with the potential for diagnostic...
3.
Yoon S, Haritunians T, Chhina S, Liu Z, Yang S, Landers C, et al.
Inflamm Bowel Dis . 2017 Jun; 23(8):1382-1393. PMID: 28590340
Background: Although anti-tumor necrosis factor (TNF) agents are effective in patients with inflammatory bowel disease (IBD), many patients either do not respond to anti-TNF treatment or lose response over time....
4.
Li X, LeBlanc J, Elashoff D, McHardy I, Tong M, Roth B, et al.
Cell Mol Gastroenterol Hepatol . 2017 Feb; 2(5):567-583. PMID: 28174738
Background & Aims: Interactions between mucosal cell types, environmental stressors, and intestinal microbiota contribute to pathogenesis in inflammatory bowel disease (IBD). Here, we applied metaproteomics of the mucosal-luminal interface to...
5.
Robbins L, Zaghiyan K, Melmed G, Vasiliauskas E, Ahmed S, McGovern D, et al.
J Crohns Colitis . 2016 Jul; 11(1):77-83. PMID: 27466172
Background And Aims: A subset of patients who undergo ileal pouch-anal anastomosis [IPAA] for ulcerative colitis [UC] will later be diagnosed with denovo Crohn's disease [CD]. These patients have a...
6.
Kaur M, Panikkath D, Yan X, Liu Z, Berel D, Li D, et al.
Inflamm Bowel Dis . 2016 Mar; 22(4):862-9. PMID: 26937622
Background: Perianal Crohn's Disease (pCD) is a particularly severe phenotype associated with poor quality of life with a reported prevalence of 12%-40%. Previous studies investigating the etiology of pCD have...
7.
Ahmed S, Melmed G, McGovern D, Robbins L, Shih D, Vasiliauskas E, et al.
Inflamm Bowel Dis . 2015 Nov; 22(3):654-61. PMID: 26595552
Background: Denovo Crohn's disease (CD) develops in 5% to 10% of patients after ileal pouch-anal anastomosis (IPAA) for ulcerative colitis (UC) leading to increased morbidity and rates of pouch failure....
8.
Taleban S, Li D, Targan S, Ippoliti A, Brant S, Cho J, et al.
J Crohns Colitis . 2015 Oct; 10(1):43-9. PMID: 26449790
Background: There has been considerable progress in identifying inflammatory bowel disease [IBD] susceptibility genes but little progress in examining the role of genetic variation in the development of the extra-intestinal...
9.
Dezfoli S, Horton H, Thepyasuwan N, Berel D, Targan S, Vasiliauskas E, et al.
Inflamm Bowel Dis . 2015 May; 21(8):1754-60. PMID: 25985242
Background: Pertussis epidemics have recently emerged across the United States, prompting broad public health recommendations for adult Tdap vaccination (tetanus, diphtheria, acellular pertussis). The impact of immunosuppressive regimens for inflammatory...
10.
Weizman A, Huang B, Targan S, Dubinsky M, Fleshner P, Kaur M, et al.
J Cutan Med Surg . 2015 Mar; 19(2):125-31. PMID: 25775631
Background: Pyoderma gangrenosum (PG) is a severe extraintestinal manifestation of inflammatory bowel disease (IBD). Objective: To better characterize PG features and management among an IBD cohort. Methods: Subjects with PG...